Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hoyer

Showing results (341-350 of 391) with videos related to

Pageof 40
Sort By:
Scientific Reports|August 17, 2017
Transcription factor ZNF148 is a negative regulator of human muscle differentiationJesse Bakke, William C Wright, Anthony E Zamora, et al.
Leukemia & Lymphoma|May 9, 2001
Fish demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosisR Fonseca, S V Rajkumar, G J Ahmann, et al.
Hemoglobin|July 30, 2002
Four new variants of the alpha2-globin gene without clinical or hematologic effects: Hb Park Ridge [alpha9(alpha7)Asn-->Lys (alpha2)], Hb Norton [alpha72(EF1)His-->Asp (alpha2)], Hb Lombard [alpha103(G10)His-->Tyr (alpha2)], and Hb San Antonio [A113(GH2)Leu-->Arg (A2)]James D Hoyer, Daniel J McCormick, Karen Snow, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2000
Design and synthesis of potent thiol-based inhibitors of endothelin converting enzyme-1C A Fink, M Moskal, F Firooznia, et al.
Hemoglobin|May 1, 1997
Hb T-Cambodia, a beta chain variant with the mutations of Hb E and Hb D-Punjab, confirmed by DNA analysisP J Hutt, V F Fairbanks, S N Thibodeau, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 13, 2014
Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexistFlavia G Rosado, Jennifer L Oliveira, Aliya R Sohani, et al.
Journal of Medicinal Chemistry|November 11, 1994
Aspartyl alpha-((1-phenyl-3-(trifluoromethyl)-pyrazol-5-yl)oxy)methyl ketones as interleukin-1 beta converting enzyme inhibitors. Significance of the P1 and P3 amido nitrogens for enzyme-peptide inhibitor bindingR E Dolle, J Singh, J Rinker, et al.
Hemoglobin|June 20, 2020
Further Characterization of Hb Bronovo [α103(G10)His→Leu; <i>HBA2</i>: c.311A>T] and First Report of the Homozygous StateNikita Mehta, J Martin Johnston, Molly Hein, et al.
Blood|November 26, 1999
Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphomaC A Hanson, P J Kurtin, J A Katzmann, et al.
Mayo Clinic Proceedings|April 10, 2007
Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic testGrzegorz S Nowakowski, James D Hoyer, Tait D Shanafelt, et al.
Pageof 40

Showing results (341-350 of 391) with videos related to

Sort By:
Pageof 40
Scientific Reports|August 17, 2017
Transcription factor ZNF148 is a negative regulator of human muscle differentiationJesse Bakke, William C Wright, Anthony E Zamora, et al.
Leukemia & Lymphoma|May 9, 2001
Fish demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosisR Fonseca, S V Rajkumar, G J Ahmann, et al.
Hemoglobin|July 30, 2002
Four new variants of the alpha2-globin gene without clinical or hematologic effects: Hb Park Ridge [alpha9(alpha7)Asn-->Lys (alpha2)], Hb Norton [alpha72(EF1)His-->Asp (alpha2)], Hb Lombard [alpha103(G10)His-->Tyr (alpha2)], and Hb San Antonio [A113(GH2)Leu-->Arg (A2)]James D Hoyer, Daniel J McCormick, Karen Snow, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2000
Design and synthesis of potent thiol-based inhibitors of endothelin converting enzyme-1C A Fink, M Moskal, F Firooznia, et al.
Hemoglobin|May 1, 1997
Hb T-Cambodia, a beta chain variant with the mutations of Hb E and Hb D-Punjab, confirmed by DNA analysisP J Hutt, V F Fairbanks, S N Thibodeau, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 13, 2014
Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexistFlavia G Rosado, Jennifer L Oliveira, Aliya R Sohani, et al.
Journal of Medicinal Chemistry|November 11, 1994
Aspartyl alpha-((1-phenyl-3-(trifluoromethyl)-pyrazol-5-yl)oxy)methyl ketones as interleukin-1 beta converting enzyme inhibitors. Significance of the P1 and P3 amido nitrogens for enzyme-peptide inhibitor bindingR E Dolle, J Singh, J Rinker, et al.
Hemoglobin|June 20, 2020
Further Characterization of Hb Bronovo [α103(G10)His→Leu; <i>HBA2</i>: c.311A>T] and First Report of the Homozygous StateNikita Mehta, J Martin Johnston, Molly Hein, et al.
Blood|November 26, 1999
Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphomaC A Hanson, P J Kurtin, J A Katzmann, et al.
Mayo Clinic Proceedings|April 10, 2007
Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic testGrzegorz S Nowakowski, James D Hoyer, Tait D Shanafelt, et al.
Pageof 40